Psychedelic Science 2023

Attending this event?

Psychedelic Science 2023

9:00am MDT

Ecopsychedelic Practices for Addressing Eco/Social Crises TBA Challenges, Opportunities and Longer Term Follow Up in MDMA-Assisted Therapy TBA Guiding Psilocybin Therapy Sessions TBA Introduction to Psilocybin as a Tool in Personal and Spiritual Development TBA Introduction to Psychedelic Care for Spiritual and Religious Care Professionals TBA Introduction to Psychedelic Neuroscience TBA Introduction to Psychedelic Therapy for Addiction TBA MDMA-Assisted Therapy Introductory Workshop TBA Psychedelic Fundamentals Workshop TBA Psychedelic Integration and Harm Reduction in Clinical Practice TBA Psychodrama and Ketamine Assisted Psychotherapy Workshop : A Novel, Accelerated Treatment Approach TBA An Introduction to Ketamine-Assisted Psychotherapy and Ketamine Methodologies TBA Grof® Breathwork: The Legacy of Stanislav Grof TBA

2:00pm MDT

Psychedelic Liberation Training: Decolonization in Practice TBA

9:00am MDT

Best Practices for Legally Protecting Sincere Psychedelic Medicine Churches TBA MDMA-Assisted Therapy Set and Setting Workshop TBA Meditation and Contemplative Science for Psychedelic Practitioners TBA Plant Medicines, Indigenous Healing Traditions and Right Relationship TBA Veterans and psychedelic therapy: An introduction for clinicians and care professional TBA Challenges, Opportunities and Longer Term Follow Up in MDMA-Assisted Therapy TBA MDMA-Assisted Therapy Introductory Workshop TBA Mobilize the Movement: Decriminalizing Psychedelics with 100 Leaders in 100 Cities in 1 Year TBA Psychedelic Fundamentals Workshop TBA The Psychedelic Industry Briefings TBA What is Psychedelic Judaism? A Jewish Psychedelic Summit Workshop TBA Zendo Project Peer Support + Harm Reduction Workshop TBA Psychedelic Therapy for End-of-Life and Palliative Care TBA

11:00am MDT

Descending the Mountain TBA

1:00pm MDT

MDMA-Assisted Therapy Music Workshop TBA

2:00pm MDT

Internal Family Systems & Psychedelic Therapy with Ketamine: Affecting Change in the Collective Sphere through Self Leadership TBA Introduction to Psychedelic Law Practice and Policy for Attorneys TBA

3:00pm MDT

We Are the Medicine TBA

3:45pm MDT

Eskawata Kayawai: The Spirit of Transformation TBA

7:10pm MDT

Wider than our View TBA

7:25pm MDT

Better Living Through Chemistry TBA

9:20am MDT

Opening address from Rick Doblin, Ph.D. TBA

10:15am MDT

Integrating Psychedelic-Assisted Therapy Into Behavioral Health TBA Accelerating Adaptation: Where Neuroscience, Wearable Technologies, AI, and Psychedelics Converge on Resilience TBA How do psychedelics work? TBA The State of the Stone: Science from the Underground TBA A History & Outlook on Psychedelic Research TBA Microdosing: Remarkable results, surprising implications TBA Beyond Medicalization: The Renaissance of Relationship TBA Understanding the landscape of state and federal reform TBA

10:30am MDT

The state of the psychedelic sector TBA Who can be a psychedelic practitioner? TBA

10:45am MDT

A conversation with Blake Mycoskie TBA Mapping the neuro-behavioral space of self-dissolution, self-other differentiation, and information processing along the psychedelic spectrum TBA Proactive harm reduction by preparing set, setting, and substance TBA What Will People Think? Revealing Public Knowledge, Belief, and Perceptions of Psychedelics TBA

11:00am MDT

Ayahuasca Diaries (Work in Progress) TBA

11:25am MDT

Prescription X: The Rick Doblin Story (Work in Progress) TBA

11:30am MDT

Recreational vs Rx Market – The Future of Natural Psychedelics in the Kaleidoscope of Evolving Regulations TBA

12:00pm MDT

Who is blind in psychedelic research? TBA Updates from leading statewide regulatory initiatives - Oregon TBA Reopening Critical Periods with Psychedelics: basic mechanisms and therapeutic opportunities TBA Laying the foundation for a new ecosystem TBA Clinical Development of MDMA-Assisted Therapy for PTSD: From Breakthrough Therapy to New Drug Application TBA Queer Medicine: Sharing the gift of your unique essence TBA Conservation and justice of peyote in the Americas TBA Responding to Crises and Calls with Psychedelic Harm Reduction TBA

12:15pm MDT

A Fireside Chat with Rick Doblin and Christian Angermeyer TBA Assessing the evidence for microdosing TBA

12:30pm MDT

Addiction, family, plant medicine, and healing TBA Amplifying the Wisdom of Psychedelic Elders TBA Molecular and neuronal responses to psychedelic-induced plasticity TBA

2:30pm MDT

Psychohistoriographic approaches to Psychedelic Assisted Psychotherapy in Jamaica TBA Building momentum for new state policy approaches TBA Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries TBA Educating the next generation of psychedelic practitioners TBA Delivering patient-centered care in a profit-focused world TBA Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations TBA A Life of Science and Dreams TBA The Mazatec Sierra and the sacred mushrooms: Past and present TBA Psychedelic education today: kids, parents, and the public TBA Find the Others: How to Build Grassroots Psychedelic Communities TBA

2:45pm MDT

Mechanisms and time-course of psilocybin-induced neuroplasticity in healthy human volunteers. TBA Preliminary results from a Pilot study of the efficacy and safety of ibogaine in the treatment of methadone detoxification TBA Decolonization and the psychedelic renaissance TBA The Unified Field theory of Psychedelic Advocacy TBA Educating the next generation of psychedelic practitioners TBA

3:00pm MDT

Regulatory considerations and opportunities TBA A conversation with Amanda Feilding and Rick Doblin, Ph.D. TBA Session to be announced TBA The Impact of Psychedelic Drugs on Brain Function and Cognition TBA Psychedelics across intersectional diasporas TBA How To Change Your Mind: MDMA TBA

3:30pm MDT

The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder TBA

3:45pm MDT

Preparing for commercialization of psychedelic-assisted therapy TBA The neural basis of the acute effects of ayahuasca TBA Psilocybin Therapy in Advanced Cancer TBA A Family Legacy: From a Mother to her Sons TBA Navigating ethical considerations in psychedelic research and therapy TBA Elephant in the Room? Safety and Abuse Liability in the Development of Psychedelic Drugs and Psychoactive Foods TBA Safety and accountability in psychedelic communities TBA Iboga and Nagoya Protocols: Model for the Psychedelic Field TBA The Psychedelic Health Equity Initiative (PHEI) TBA Psilocybin Mushrooms and their Tryptamines: Potential Medicines for Neurogeneration TBA Increasing safety and participation in psychedelic research and communities among people of the global majority and gender/sexually expansive people TBA

4:08pm MDT

The biological antidepressant effects of Ayahuasca TBA

4:15pm MDT

Pragmatic Trial of Psilocybin Therapy in Palliative Care: A Multicenter Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life TBA Messages From the Underground and Other Elephants in the Room TBA Swimming in the sacred: Wisdom from the psychedelic underground TBA Managing hype, expectation, and risks in psychedelic therapy TBA

4:30pm MDT

Rave as Ritual: The Intersection of Collective Movement and Entheogens TBA The neuroscience of DMT: Past, present, and beyond TBA

5:00pm MDT

Building the next generation of psychedelic care clinics TBA Grof Legacy TBA

5:15pm MDT

Panel discussion on psilocybin therapy for cancer patients and palliative care TBA Psychedelics in the Wild: Re-creating “Recreational” TBA Sleep, Dreams, and Psychedelics TBA Stealing Fire: How to Keep the Psychedelic Revolution Burning Brightly TBA Preparing for inspections of trial sites by the FDA TBA BIPOC Psychedelic Speed-Friending TBA How Psychedelic Medicine Can Unlock Elite Performance TBA Appropriation, appreciation, and right relationship TBA Law enforcement, first responders, and drug policy reform TBA Embedding Health Equity Principles into Psychedelic-Assisted Therapy and Education TBA

5:30pm MDT

Building the next generation of psychedelic retreat centers TBA

5:45pm MDT

Mind-bending, mind–“mending”? The effect of psychedelics on flexible cognition, and underlying neural mechanisms TBA Psilocybin-assisted therapy for frontline clinicians TBA Cartography of the Soul: Artist Spotlight with 1OF1 and Christie's TBA Satire is sacred: the role of humor in keeping us “sane” TBA

6:15pm MDT

Welcome Reception in the Exhibition Hall TBA

7:00pm MDT

Peace of Mind TBA

7:30pm MDT

Wednesday, June 21, 2023 Opening Dinner Honoring Roland R. Griffiths, PhD Colorado Convention Center A Ceremony of the Psychedelic Story TBA

7:50pm MDT

Journey Through Nature TBA

7:00am MDT

Psychedelic Business Breakfast on June 22 featuring the latest updates on drug discovery, financing, and partnerships shaping the next year of the psychedelic industry. Colorado Convention Center

9:15am MDT

Psychedelics: Spirituality, Mindfulness, and Mortality – Personal reflections and visions for the future TBA

10:15am MDT

Psychedelics as The Great Disrupters: Reconstructing the Future of Mental Healthcare TBA Effects of Psilocybin in Alcohol Use Disorder: Beyond Reduction TBA BioGnosis: Building Bridges: Connecting Science and Ancestral Wisdom TBA Psychedelics therapeutics: What we know, what we think, and what we need to research TBA Storytelling, grief, and liberation TBA The Potential of Psychedelic Therapies for Veterans and their Families TBA “Show Me the Data” – Navigating Psychedelic Naysayers TBA Religious Leaders / Psychedelic Access TBA The Opportunities and Challenges for New Psychedelic Researchers to Receive NIH Funding — Heffter Research Institute and International Society for Research on Psychedelics TBA Do's and Don'ts of Filing a RFRA Lawsuit - Religious Use Claims and Defenses TBA Effects of Psilocybin-Facilitated Experience on Religious Leaders: Quantitative and Qualitative Findings from the Johns Hopkins and NYU study TBA

10:30am MDT

Lessons from the first three years of psychedelic public companies TBA The State of Psychedelic Science Since 2017 TBA Pioneers of MDMA Therapy: Reflections on 20+ Years of MDMA Therapy and Research TBA

10:45am MDT

Psilocybin Treatment of Tobacco Addiction: From a Wing and a Prayer to Federally Funded Psychedelic Therapy Research TBA Intercultural entheogenic medicine in the treatment of addictions and other mental health challenges TBA Exploring the Use of Human Brain Organoids to Study Psychedelics TBA Healing, activism, and our precious earth TBA New Federal Support for Research TBA

11:00am MDT

A Table of Our Own TBA

11:30am MDT

Session to be announced TBA

12:00pm MDT

Ayahuasca-assisted addiction treatment in Peru: results, challenges, and promises from a multi-year, mixed-methods study at Takiwasi Center TBA A Study of Oral Ibogaine in Opioid Withdrawal and Relapse Prevention TBA Confessions of the Psychedelic Elders TBA The promise of policy reform in Mexico TBA Naturalistic Psilocybin Use is Associated with Persisting Improvements in Mental Health and Well-being in a Large Prospective Sample TBA Beyond symptom reduction: Lessons about the Nature of Healing TBA Growing up: The next cycle of venture funding for psychedelic companies TBA The Nature Medicine Health Act of Colorado: Progress For Who, How We Got Here, and Where We Go Next? TBA The Story of Psychedelic Research for Veterans TBA

12:15pm MDT

Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts TBA Reflections on a Lifetime with Psychedelics TBA

12:30pm MDT

Investigating the health outcomes of ceremonial ayahuasca use in refugees and immigrants TBA Panel discussion and Q&A with addiction researchers TBA Cat's Outta the Bag: How LSD Escaped into the General Public TBA Psychedelic Training: Bridging Clinical Trials with Community Practice TBA Wellness and Psychedelics: Exploring the Data from 3000+ Individuals TBA Trauma and psychedelic-assisted therapy TBA

12:45pm MDT

Baseline predictors of acute ayahuasca effects among people attending ceremonial retreats in Costa Rica: A preliminary analysis from a longitudinal study TBA

2:30pm MDT

Building community-oriented therapy practices TBA Innovations in Global Healthcare and Lessons for Psychedelics TBA Psilocybin-assisted Therapy for Major Depressive Disorder: Clinical Results and Cases From a Placebo-controlled, Fixed-order Trial TBA History and archeology of psilocybin mushrooms in Mesoamerica TBA The Psychedelic Discovery Process TBA Buddhism and Psychedelics TBA Fostering Community Among Justice Impacted People TBA Improving study design in trials using psychedelic-assisted therapies TBA Veterans and the Journey of Plant Medicine TBA

2:45pm MDT

Building community-oriented therapy practices TBA Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse TBA

3:00pm MDT

Latest developments in Clinical studies for Depression TBA A conversation with Norma Lotsoff TBA Session to be announced TBA Alexander Shulgin Research Institute: Chemistry for Consciousness TBA Christianity and Psychedelics TBA Panel discussion on building community-oriented therapy practices TBA Of Night and Light: The Story of Iboga and Ibogaine TBA

3:45pm MDT

The healthcare economics of psychedelic drugs and care TBA The development of novel non-hallucinogenic drugs based on known psychedelics TBA Ketamine Treatment: Current Issues and Controversies TBA Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study TBA What Psychedelics Can Teach Us About Love TBA Surviving NXIVM, cults, and sexual violence: A story of abuse, healing, and ketamine-assisted therapy retreats TBA When psychedelic ritual migrates online TBA Islam and Psychedelics TBA Trauma Support for the Families of Veterans TBA Successful Protocol Designs for Psychedelic Clinical Trials – Use of Imaging, Biomarkers and Patient-Reported Outcomes TBA Indigenous Affinity: The Impacts of Legislation on Native Communities TBA International psychedelic policy highlights TBA

4:00pm MDT

Functional Selectivity and Drug discovery for Novel Psychedelic Anti-Inflamamtories TBA Achieving market access and reimbursement for psychedelic therapy TBA Group administration and integration in psychedelic therapy TBA Panel discussion: The state of ketamine-assisted therapy TBA

4:15pm MDT

The mirror molecule: Ketamine as an addictive and anti-addictive, as poison and promise TBA Psychedelics and raising families TBA An old new dream: rebuilding society in the light of mystical insight TBA Panel discussion post-presentation TBA Judaism and Psychedelics TBA

5:00pm MDT

Session to be announced TBA

5:15pm MDT

MDMA-Assisted Therapy in The Treatment of Eating Disorders in Association With PTSD TBA Efforts to Overcome New Drug Development Challenges TBA Building reciprocity in psychedelic companies TBA The Canadian Psychedelic Survey; Results of a Large Cross-Sectional Survey of Canadian Adults Who Use Psychedelics TBA Buddhism and Plant medicine; An Acceleration of Insight and Healing TBA Bridging traditional approaches with contemporary practice TBA Borderline Personality Disorder and the potential of psychedelic-assisted therapy TBA Psychedelics for First Responders: A Storytelling & Sharing Hour TBA

5:30pm MDT

Effects of Psilocybin in Anorexia Nervosa TBA Mystical Crystals: The Chemistry of Psilocybin TBA

5:45pm MDT

Psilocybin as a Treatment for Anorexia Nervosa (PANOREXIA): Pilot Study 6-Week Follow-Up Results TBA Wonder and Healing at an Ayahuasca Centre, Peru TBA Psychedelics & Psychosis: The Latest Science TBA Aligning purpose, profit, and public benefit in psychedelic businesses TBA Choreographing re-membrance: The Santo Daime bailado as danced epistemology TBA Considering psychedelic therapy for adolescents TBA

6:00pm MDT

Panel discussion on eating disorders TBA Family Matters in Psychedelic Therapy: Maximizing Positive Outcomes and Minimizing Systemic Distress TBA

6:15pm MDT

Networking Reception in Exhibition Hall TBA

7:00pm MDT

Psychedelic Revolution: The Secret History Of The LSD Trade TBA Thursday, June 22, 2023 Healing Our Heroes: A Dinner Honoring Veterans and First Responders Colorado Convention Center

9:15am MDT

A Message From The Amazon TBA

10:15am MDT

A randomized controlled trial of LSD-assisted psychotherapy to treat metastatic cancer induced bone pain TBA Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD TBA The Chapel of Sacred Mirrors TBA 5-MeO-DMT as a mental health tool: exploring possible mechanisms of action, the reactivation phenomenon, and some ethical considerations regarding the Sonoran Desert toad TBA MDMA & Developmental Trauma: Transformation of Self-Awareness & Self-Compassion TBA An Overview of Current State Frameworks for Psychedelic Healing TBA Patents, commons, and innovation in psychedelic drug development TBA Asian Homecoming: A gathering for all Asians (East, West, South, Central, bicultural, diaspora) TBA From personal to collective: ayahuasca as a peace-making tool among Palestinians and Israelis TBA From drug policy to public health and beyond TBA Benefits of assessing biomarkers in psychedelic trials TBA

10:45am MDT

Emerging research on psychedelic therapies for the treatment of pain TBA Learnings, wisdom for therapists considering offering psychedelic-assisted therapy TBA From observational research to therapeutic applications: 5-MeO-DMT TBA IFS as a Safe and Deep Healing Map to Psychedelic Territory TBA

11:00am MDT

BioGnosis: Bridges to Ancestral Wisdom TBA

12:00pm MDT

Indigenous Uses of Psilocybin Mushrooms and Psychedelic Capitalism TBA Telemedicine models for supporting psychedelic therapy TBA Critical perspectives on critical issues: IP TBA Toward “next generation” ketamine treatment: from new insights into the neurobiology of depression to strategies to optimize ketamine efficacy TBA Sex and Psychedelics: Weaving Altered States for Healing and Pleasure TBA Psilocybin administration for therapist training: outcomes from a world-first trial TBA Integrating Indigenous Wisdom into Psychedelic Therapy TBA Regulating State Markets for Psychedelic-Assisted Services TBA Art Integration, Peer Support, and Veteran Healing Journeys TBA Begrijpt u nu waarom ik huil? (Now do you get it?) TBA

12:15pm MDT

Psychedelic drugs as a potential treatment for headache disorders TBA Plant medicine and reciprocity TBA

12:30pm MDT

A trial of ketamine masked by surgical anesthesia in depressed patients TBA Next generation assistive tech for psychedelic therapy TBA New Directions for Psychedelic Therapies: Exploring Psilocybin in Alzheimer's Disease and Chronic Lyme Disease TBA Critical perspectives on critical issues: data and privacy TBA Breaking Patterns and Finding Meaning: A Study on Low-Dose LSD TBA Spiritual Healing in Psychedelic Psychotherapy TBA

12:45pm MDT

Grounding Psychedelic Research in Memory for Advancing Psychedelic Drug Discovery TBA

2:30pm MDT

Comparative Conspirituality: A Decolonial Approach From the Global South TBA Beyond Ecstasy: Progress in Developing and Understanding a Novel Class of Therapeutic Medicine TBA Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries Colorado Convention Center Psychedelic Outcomes: Intersection of Environment, Self-Identity, and Success ( The POIESIS Study) TBA Innovation, privacy, and data science in psychedelic therapy TBA Psychedelic therapy for depression: A DMT approach TBA How to Get Involved and Participate in State Ecosystems TBA Have a Safe Trip: Navigating the Complexities of Psychedelic Research and Harm Reduction TBA The Responsibility of Psychedelic Journalism TBA Couples therapy and psychedelic-assisted therapy TBA

2:45pm MDT

Psychedelics as relational medicines: Investigating the role of psychosocial factors for outcomes of clinical and naturalistic psychedelic use TBA Potentialities and Challenges of Ayahuasca in the Psychedelic Renaissance TBA

3:00pm MDT

Effects of psilocybin-assisted psychotherapy on personality and their relationship with self-compassion among individuals with alcohol use disorder TBA The future of psychedelic manufacturing TBA Safety, tolerability, and effects of vaporized DMT on cognition TBA A conversation with Carl Hart, Ph.D. TBA The Way of the Psychonaut: Stanislav Grof and the Journey of Consciousness TBA

3:15pm MDT

Psychedelic Personality Change: Observations, Mechanisms, and Limitations TBA

3:45pm MDT

Mental well-being changes in older adults attending ceremonial psychedelic group sessions TBA The War in Ukraine and Psychedelic-Assisted Therapy TBA Underground History and Overground Future TBA An Overview of State Psychedelics Projects TBA So you want to be a psychedelic professional TBA Queering Psychedelics TBA Designing a post-prohibition future TBA

4:00pm MDT

The Love Project: Preliminary outcomes of a survey study among psychedelic users TBA The telescope of the mind: Can psychedelics provide insights into consciousness? TBA Psychedelics, addiction, and recovery TBA

4:15pm MDT

Psychedelics and Sexual Functioning: a Mixed-Method Study in Healthy and Depressed Subjects TBA Female leadership in the psychedelic industry TBA Transformational synergies: Together, MDMA and experiential-relational psychotherapeutic interventions can accelerate the healing of attachment trauma TBA Psychedelics and artificial intelligence TBA

4:30pm MDT

Psychedelics during the global crisis: 3 years of longitudinal assessments TBA

5:00pm MDT

Indigenous Perspectives on the Globalization of Ayahuasca TBA Lessons from the cannabis industry TBA Unresolved Issues in the Psychedelics Community TBA A conversation with Ethan Nadelmann TBA Psychedelics, joy, and celebration TBA

5:15pm MDT

Peyote History and Politics in Mexico TBA The Global Psychedelic Society: Resourcing, Connecting, & Supporting Psychedelic Community Worldwide TBA

5:30pm MDT

Dismantling the Myth of “Mother Ayahuasca” TBA Becoming a Psychedelic Therapist TBA